{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T22:59:19Z","timestamp":1788044359104,"version":"build-2784847793"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Severe hypocalcemia is a common complication in patients with secondary hyperparathyroidism (SHPT) after parathyroidectomy (PTX). The necessity of postoperative prophylactic intravenous calcium supplementation and the corresponding strategies are controversial. This study aimed to analyze the efficacy and safety of prophylactic intravenous calcium supplementation after PTX.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed the clinical data of 125 patients with SHPT who underwent PTX between January 2020 and December 2023. Patients were divided into prophylactic intravenous calcium supplementation group (group A, 94 cases) and non-prophylactic intravenous calcium supplementation (group B, 31 cases). The baseline characteristics, laboratory data, surgical outcomes of the two groups were compared. Binary logistic regression analysis was used to identify risk factors for severe hypocalcemia and hypercalcemia after calcium supplementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The incidence of severe hypocalcemia in group A (30 cases, 31.9%) was lower than that in group B (19 cases, 61.3%) (P = 0.004). Binary logistic regression analysis revealed that non-prophylactic intravenous calcium supplementation, high level of preoperative parathyroid hormone (PTH) and alkaline phosphatase (ALP), and low level of preoperative serum calcium were risk factors for severe hypocalcemia. Preoperative high level of ALP was a negative predictor for hypercalcemia after calcium supplementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Postoperative prophylactic intravenous calcium supplementation, followed by dynamic dosage adjustments based on serum calcium levels, in addition to routine oral calcium and calcitriol supplementation, could significantly reduce the incidence of severe hypocalcemia without substantially increasing the risk of hypercalcemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1652418","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T05:15:00Z","timestamp":1763961300000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of prophylactic intravenous calcium supplementation in patients with secondary hyperparathyroidism after parathyroidectomy: a retrospective study"],"prefix":"10.3389","volume":"16","author":[{"given":"Yao","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenglong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1059828","article-title":"Advances in the treatment of secondary and tertiary hyperparathyroidism","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/nu14153009","article-title":"Vitamin D and secondary hyperparathyroidism in chronic kidney disease: A critical appraisal of the past, present, and the future","volume":"14","author":"Brandenburg","year":"2022","journal-title":"Nutrients."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2012.12.017","article-title":"Chronic kidney disease: mineral and bone disorder in children","volume":"33","author":"Wesseling-Perry","year":"2013","journal-title":"Semin Nephrol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-019-05033-3","article-title":"Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease","volume":"30","author":"Geng","year":"2019","journal-title":"Osteoporos Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2023.10.003","article-title":"Preoperative work-up and results of parathyroidectomy plus auto-transplantation for the elderly with secondary hyperparathyroidism","volume":"47","author":"Chou","year":"2024","journal-title":"Asian J Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinme.2024.100238","article-title":"Secondary hyperparathyroidism in chronic kidney disease: A narrative review focus on therapeutic strategy","volume":"24","author":"Tsai","year":"2024","journal-title":"Clin Med (Lond)."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1169793","article-title":"Treatment for secondary hyperparathyroidism focusing on parathyroidectomy","volume":"14","author":"Hiramitsu","year":"2023","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.11.023","article-title":"Surgical management of secondary hyperparathyroidism","volume":"6","author":"Steinl","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000327","article-title":"Hungry bone syndrome","volume":"26","author":"Jain","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B10","doi-asserted-by":"publisher","first-page":"9548","DOI":"10.1038\/s41598-022-13880-0","article-title":"A predictive risk score to diagnose hypocalcemia after parathyroidectomy in patients with secondary hyperparathyroidism: a 22-year retrospective cohort study","volume":"12","author":"Phimphilai","year":"2022","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13111953","article-title":"Forestalling hungry bone syndrome after parathyroidectomy in patients with primary and renal hyperparathyroidism","volume":"13","author":"Carsote","year":"2023","journal-title":"Diagnostics (Basel)."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad636","article-title":"Predictive risk score for postparathyroidectomy hungry bone syndrome in patients with secondary hyperparathyroidism","volume":"109","author":"Amjad","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8752826","article-title":"Prediction model of postoperative severe hypocalcemia in patients with secondary hyperparathyroidism based on logistic regression and XGBoost algorithm","volume":"2022","author":"Ding","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/1901697","article-title":"Risk Factor Analysis and Prediction of Severe Hypocalcemia after Total Parathyroidectomy without Auto-Transplantation in Patients with Secondary Hyperparathyroidism","volume":"2023","author":"He","year":"2023","journal-title":"Int J Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.21037\/apm-21-2509","article-title":"Predictive markers for severe hypocalcemia in dialysis patients with secondary hyperparathyroidism after near-total parathyroidectomy","volume":"10","author":"Zou","year":"2021","journal-title":"Ann Palliat Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.10390917","article-title":"Parathyroidectomy in the management of secondary hyperparathyroidism","volume":"13","author":"Lau","year":"2018","journal-title":"Clin J Am Soc Nephrology: CJASN."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202403_35726","article-title":"Predictive analysis of severe hypocalcemia following total parathyroidectomy for renal secondary hyperparathyroidism","volume":"28","author":"Bi","year":"2024","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14020379","article-title":"Determinants of severe hypocalcemia after parathyroidectomy in patients with end-stage kidney disease and renal hyperparathyroidism: A retrospective cohort study","volume":"14","author":"Tan","year":"2025","journal-title":"J Clin Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1040264","article-title":"Construction and validation of a predictive model for hypocalcemia after parathyroidectomy in patients with secondary hyperparathyroidism","volume":"13","author":"Cheng","year":"2022","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/nu14102124","article-title":"Alkaline phosphatase: an old friend as treatment target for cardiovascular and mineral bone disorders in chronic kidney disease","volume":"14","author":"Haarhaus","year":"2022","journal-title":"Nutrients"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-020-02387-0","article-title":"Hungry bone syndrome after parathyroidectomy in end-stage renal disease patients: review of an alkaline phosphatase-based treatment protocol","volume":"52","author":"Wong","year":"2020","journal-title":"Int Urol Nephrol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6613659","article-title":"Risk factors for severe hypocalcemia in patients with secondary hyperparathyroidism after total parathyroidectomy","volume":"2021","author":"Wen","year":"2021","journal-title":"Int J Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1530\/EC-23-0107","article-title":"Hungry bone syndrome in peritoneal dialysis patients after parathyroid surgery","volume":"12","author":"Yeh","year":"2023","journal-title":"Endocr Connect"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-023-07030-4","article-title":"Pre-operative cinacalcet administration reduces immediate post-operative hypocalcemia following total parathyroidectomy in severe renal hyperparathyroidism","volume":"47","author":"Fung","year":"2023","journal-title":"World J Surgery."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1652418\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T05:15:01Z","timestamp":1763961301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1652418\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":25,"alternative-id":["10.3389\/fendo.2025.1652418"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1652418","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"article-number":"1652418"}}